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ABSTRACT 
REDUCING HYPOTENSION IN ELECTIVE CESAREAN SECTION PATIENTS 
WITH ADMINISTRATION OF ONDANSETRON PRIOR TO SPINAL 
ANESTHESIA: A RETROSPECTIVE CHART ANALYSIS 
by Linsey Erin Phipps 
December 2016 
The birth of a child is one of the most memorable moments in a woman’s life, and 
many women undergo an elective cesarean section, requiring spinal anesthesia.  At this 
time, the patient and the unborn child’s well-being become the anesthetist’s main focus.  
The ultimate goal of anesthesia providers is to provide the safest care to the patient.  
Spinal anesthesia has many benefits, but has a common side effect of hypotension, which 
can also result in nausea.  Hypotension, dangerous to mother and child, is often treated 
with vasopressors, but can also cause nausea, which is treated by the administration of 
ondansetron.  A retrospective chart review (N=114) was performed to examine if the 
administration of ondansetron prior to spinal anesthesia in elective cesarean section 
patients reduced the occurrence of hypotension.  Inclusion criteria consists of patients 
receiving spinal anesthesia for elective cesarean sections, ages 20-40 years, ondansetron 
only given prior to spinal anesthesia, ondansetron given in ten minutes or less before 
spinal anesthesia and met the American Society of Anesthesiologist’s (ASA) patient 
status classification I or II.  Exclusion criteria includes patients presenting for cesarean 
section with epidural due to failure to progress, ASA patient status classification III, IV 
or V, emergent cesarean sections, multiple parities (twins/triplets), > 1,000 ml blood loss, 
> 6 mg ondansetron administered, patients presenting with a cardiac history (coronary 
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artery disease, myocardial infarction, congestive heart failure, murmur, mitral valve 
prolapse/regurgitation, dysrhythmias, aortic stenosis/regurgitation) and patients 
presenting with preeclampsia.  A Chi Square test was performed, which indicated no 
significant association between administering ondansetron and the occurrence of 
hypotension (df=1, x2 (1) = .035, p= .851).  A secondary analysis was performed, which 
did show a significant association between administering ondansetron and the reduced 
usage of vasopressors to increase blood pressure (df=1, x2(1) = 6.437, p= .011).  This 
evidence indicates that though ondansetron did not result in reducing hypotension, it did 
result in decreasing the amount of vasopressors used to maintain blood pressure, which in 
turn decreased vasopressor adverse side effects to mother and unborn child. 
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CHAPTER I - INTRODUCTION 
When women enter the hospital for an elective cesarean section, they are given 
the option of general, spinal, or spinal/epidural combined anesthesia.  The risk factors and 
benefits of each procedure are explained to the patient by the anesthesia provider.  The 
primary anesthetic procedure used at this time is spinal anesthesia (Sirajuddin, Abbas, 
Murtaza, & Naqvi, 2013). Nagelhout and Plaus (2014) state “single shot spinal anesthesia 
is the most common used anesthetic technique for cesarean section deliveries because this 
technique offers many distinct advantages” (p. 1142).  The advantages of spinal 
anesthesia include rapid onset, a more reliable block, and uses less toxic doses of local 
anesthetics compared to epidural anesthesia.  Though there are many advantages that 
come from the use of spinal anesthesia, there are also some disadvantages.  A few of the 
disadvantages when using spinal anesthesia include a chance of having a failure of the 
block, the fixed amount of time that a particular drug is effective, and sympathectomy 
with resultant hypotension and bradycardia.  Farmawy and Rashad (2013) stated that 
hypotension represents the incidence of about 55-100%, making it the most frequent 
complication.  Adults can walk around with low blood pressure every day, for a pregnant 
woman and her unborn child, hypotension needs to be treated.  Hypotension in a pregnant 
woman can cause unconsciousness, which can lead to aspiration.  It may also cause 
cardiac issues and decreased perfusion to the unborn child (Nagelhout & Plaus, 2014). 
Clinical Question 
Does ondansetron, a 5HT3 antagonist used commonly to treat nasusea, help 
reduce the hypotension associated with spinal anesthesia in women having a cesarean 
section?  By understanding the effects ondansetron has on the body, healthcare providers 
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can capitalize on the benefits this medication can bring to pregnant women receiving the 
medication before the placement of spinal anesthesia.  The use of ondansetron prior to 
spinal placement has been shown to reduce the excessive use of fluids and the need to use 
vasopressors to combat hypotension during the case (Farmawy & Rashad, 2013).  
Reducing the utilization of other medications and multiple bags of fluid will in turn 
reduce costs for the hospital and pharmacy.  The proposed mechanism of ondansetron is 
the antagonism by the 5HT3 receptors in the intracardiac vagal nerve endings in the 
Bezold Jarisch reflex (Nagelhout & Plaus, 2014).  Understanding the different responses 
activated by certain medications help make spinal anesthesia safer for pregnant women.  
Studies show that the use of opioid medications cause hypotension and that ondansetron 
can assist in reversing the hypotensive response.  The opioid pathways in the brain are 
crucial in the hypotensive response detected after the 5HT3 antagonist receptor 
stimulation.  By being more aware of the pain medications given to the patients, a better 
understanding of the side effects can be realized, and some may be able to be reversed by 
ondansetron. 
Whether fluids, vasopressors or ondansetron are used to treat hypotension related 
to spinal anesthesia, hypotension must be treated to prevent further deterioration of the 
patient.  Patient safety is the number one goal during the hospital stay.  Evidence must be 
used to determine the most appropriate ways to increase patient safety and satisfaction.  
Ondansetron could be the most useful and cost effective way to maintain hemodynamics 
in pregnant women while undergoing spinal anesthesia. 
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Background and Significance/Problem Statement 
Spinal anesthesia has the potential to produce several undesirable problems; the 
main one being hypotension.  Nagelhout and Plaus (2014) state “when spinal anesthesia 
is used to produce the T4 (thoracic vertebrae 4) block needed for cesarean section, 
hypotension has been shown to occur in up to 80% of patients despite the patient being 
placed in left uterine displacement” (p. 1143).  Typically, hypotension is treated with 
either large amounts of fluid therapy or vasopressors.  Fluid therapy has been shown to 
provide positive outcomes in helping to reduce hypotension, but it can also lead to fluid 
overload and urinary retention.  Patients with an underlying history of cardiac issues, 
such as congestive heart failure, will be unable to receive the typical one liter of fluid 
prior to spinal anesthesia.  These patients are at a disadvantage and more prone to 
developing severe hypotension.   
Ephedrine is the most common vasopressor used to treat maternal hypotension.  
Ephedrine is a synthetic, noncatecholamine sympathomimetic drug.  Ephedrine is 
typically administered in doses ranging from five to twenty-five milligrams intravenously 
to treat acute decreases in blood pressure (Nagelhout & Plaus, 2014).  According to 
Nagelhout and Plaus (2014), the effect of five to ten milligram intravenous doses usually 
persists for five minutes and the duration of ephedrine’s cardiovascular effects varies 
with each dose.  Another drawback to the use of this medication is the possibility of 
tachyphylaxis.  Tachyphylaxis can occur with repeated small dosing of ephedrine, which 
results in a decreased clinical effect after subsequent dosing.  The issue of constant 
redosing and unreliability of duration of action show the drawbacks of using this 
medication to treat maternal hypotension.  Nagelhout and Plaus (2014) state “recent 
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evidence suggests that ephedrine may cross the placenta and stimulate fetal β-adrenergic 
receptors, resulting in depression of fetal acid –base balance” (p. 1143).  This makes its 
repeated use less than desirable. 
Evidence of Problem/Local Need 
Spinal anesthesia causes predictable and controllable physiologic changes that 
require minimal intervention if detected early.  The spinal anesthetic causes a 
sympathetic nerve blockade, which in turn causes vasodilation, decreased venous return 
and decreased systemic vascular resistance.  The changes that are caused by the 
sympathetic blockade in turn change the redistribution of blood and lead to hypotension.  
According to Nagelhout and Plaus (2014), “hypotension is immediately relevant to the 
perfusion of critical organs such as the heart and brain and is important to all organs in 
maintaining near homeostasis” (p. 1083).  
When discussing the issue of spinal anesthesia and hypotension with anesthesia 
providers, there was a consensus that there is an issue in the obstetric population and a 
need to reduce the harmful side effects.  In an interview with a local CRNA at my 
practice site (July 10, 2015), the issue of hypotension associated with spinal anesthesia 
was addressed as well as why he chose to administer ondansetron to help reduce this side 
effect.  The CRNA stated he started using ondansetron in the obstetric population to help 
reduce hypotension after spinal anesthesia after he attended a Continuing Education (CE) 
meeting discussing this issue.  After learning of its use he brought this information back 
to the practice site and started administering it to the obstetric patients receiving elective 
cesarean sections and spinal anesthesia.  The CRNA stated approximately 70% of the 
patients receiving ondansetron required zero or a drastically decreased amount of blood 
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pressure support.  Ondansetron, four milligrams, is given usually after the preoperative 
interview if the patient is being taken directly back to the operating room.  The CRNA 
said he has seen a decrease in the amount of vasopressors being used during the 
procedure due to the administration of ondansetron prior to spinal anesthesia.  
Hypotension after spinal anesthesia for cesarean section patients has been an ongoing 
issue for this population, the ability to administer a medication that will help reduce this 
side effect and help make it safer for mother and child is of the utmost importance. 
Purpose of the Project 
The aim of this doctoral project is to examine clinical evidence to support a 
practice change to reduce the amount of vasopressors administered to cesarean section 
patients receiving spinal anesthesia by administering ondansetron, thereby reducing 
hypotension related to this particular population and increasing patient safety.  Evidence 
of the relationship between the administration of ondansetron prior to spinal anesthesia in 
cesarean section patients and reduced hypotension, and decreased use of vasopressors 
will be done via a retrospective chart review.  As healthcare providers, our duty is to 
provide care that is efficient and harmless to our patients.  Healthcare providers must 
evaluate the medications and procedures used and determine if evidence supports 
enhancements in the care the patient receives during their stay.  Patients come to the 
hospital wanting to feel safe and assume the safest, most current forms of treatment are 
being used.  Through establishing the evidence linking ondansetron to hypotension, when 
administered prior to spinal anesthesia for a cesarean section, a change in current practice 
may be indicated.  Findings will be presented to key stakeholders in an educational 
presentation.  The educational presentation will disseminate the evidence of relationship 
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of ondansetron, administered prior to spinal anesthesia in cesarean section patients, to 
hypotension, and the use of vasopressors.  See Appendix D and E for project logic model 
and SWOT analysis. 
Theoretical Framework 
The theory used that represents the concepts of preventing hypotension related to 
spinal anesthesia for a cesarean section is The Theory of Human Caring (Watson, 1979).  
This theory incorporates the human being, health, environment, and nursing; the nursing 
model is concerned with promoting the patient’s health, preventing illness, caring for the 
sick and restoring the patient’s health (Watson, 2008).  The healthcare provider uses the 
nursing process to evaluate the patient.  Care plans are developed to help the healthcare 
provider determine individual variables that would be included/examined and what data 
will be collected; this is the intervention phase.  Evaluation of all data collected and 
analyzing the results may likely lead to a new idea regarding the problem.  In this theory, 
caring is a key component that will result in the promotion of the patient’s health and 
satisfaction of their needs.  Identifying the problem, building a relationship with the 
patient that promotes faith and hope in the provider, discussing the problem and options 
with the patient, developing a plan for the patient and the problem, all come together in 
covering Watson’s 10 carative factors and make her framework a good fit for this 
doctoral project. 
Doctor of Nursing Practice Essentials 
This doctoral project fulfills and applies the 8 practice essentials of the doctor of 
nursing practice essentials.  This doctoral project meets all eight essentials (See Appendix 
B), but the main essentials addressed are Essential IV and VI.  In looking at Essential IV, 
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there was a retrospective chart review and de-identified patient data was extracted from 
their electronic medical record and protected to avoid ethic/legal issues.  Electronic 
databases were used for review of literature and to obtain information regarding 
ondansetron and spinal anesthesia on cesarean section patients.  Essential VI was met by 
collaboration with anesthesia providers which is pivotal to bringing about a practice 
change.  Each provider has vital information and suggestions that can help bring about a 
change and help in providing the safest care to the patient population.  Another vital 
component in collaboration for this project, is that of the Electronic Patient Integrated 
Care (EPIC) technology staff and the researcher.  Without this collaboration, the 
information for the project would not have been available. 
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CHAPTER II – REVIEW OF LITERATURE 
A literature search was conducted to determine if the incidence of hypotension 
with spinal anesthesia is reduced if ondansetron is given prior to the procedure for 
women receiving an elective cesarean section.  A comprehensive review of literature was 
performed.  Article inclusion criteria were as follows: 1) articles must relate to spinal 
anesthesia and the use of ondansetron, 2) must be written in English 3) searches were 
limited to peer-reviewed articles appearing in scholarly journals in the past five years.  
The search consisted of multiple databases accessed through USM's online catalog.  The 
databases used were PubMed, Cochrane, CINAHL with Full Text, and Medline.  The 
search terms used were ondansetron, hypotension, spinal anesthesia and cesarean 
section.  One hundred sixty-eight articles were found. Six articles met inclusion criteria.  
After an initial review, the final six articles consisted of systematic, meta-analysis and 
integrative reviews of control trials.  Information from the articles was placed into a 
literature matrix.  (See Appendix A) 
Synthesis of Literature 
Spinal anesthesia has become a safe alternative to general anesthesia for surgical 
interventions.  Though the procedure has many advantages, the disadvantages such as 
cardiovascular effects can be detrimental.  The most common issues expressed are 
hypotension and bradycardia.  Spinal anesthesia decreases vascular resistance and 
stimulates the Bezold-Jarisch reflex.  The responses in turn cause vasodilation and 
bradycardia, which result from the stimulation of the 5HT3 receptors in the vagal nerve 
endings (Owczuk et al., 2008).  
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Owczuk et al. (2008) implemented a study to validate their hypothesis that 
blocking type three serotonin receptors by introducing ondansetron intravenously would 
reduce hypotension and bradycardia induced by spinal anesthesia.  Seventy-one adult 
pregnant patients participated in the study.  Patients were randomly placed into two 
groups.  The ondansetron group contained 36 patients who received 8 mg of ondansetron 
diluted in 10 ml normal saline.  The placebo group included 35 patients who were 
administered 10 ml of normal saline.  Baseline measurements were obtained five minutes 
prior to the spinal anesthetic and every five minutes throughout the procedure.  There was 
a decrease in the mean arterial pressure (MAP), systolic arterial pressure (SAP), and 
diastolic arterial pressure (DAP) in both groups when compared to the baseline 
measurements with the heart rate (HR) values remaining unchanged.  The ondansetron 
group showed a higher SAP when measurements were taken at the 10, 15 and 20-minute 
marks.  The MAP, DAP, and HR had no significant changes in the two groups at these 
minute marks.  A SAP drop below 90 mmHg was detected in 7 patients in the placebo 
group and 1 patient in the ondansetron group (20% vs. 2.8%) this difference was 
statistically significant ( p=.028) (Owczuk et al., 2008).  The study concluded there was 
no definite evidence that the ondansetron had more advantages than administration of 
vasopressors, but its use may be more beneficial for particular groups of patients.  One 
population of patients is pregnant women, in which the administration of vasopressors 
can have adverse effects on uterine blood flow, and may not be the optimal choice.  
In a study conducted by Sahoo, SenDasgupta, Goswami, and Hazra (2012) the 
authors hypothesized that spinal induced hypotension and bradycardia could be 
minimized with ondansetron in non-laboring obstetric patients undergoing a cesarean 
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section.  This study consisted of 52 patients scheduled for cesarean sections who were 
randomly placed into two groups.  Group O consisted of 26 patients receiving 4 mg of 
ondansetron.  Group S consisted of 26 patients receiving 10 ml normal saline.  Heart rate, 
blood pressure, and vasopressor use were measured with each group.  Decreases in mean 
arterial pressure were significantly lower in Group O.  Patients in Group O required 
significantly less vasopressor (p=0.009) (Sahoo et al., 2012).  The use of ephedrine and 
the incidence of nausea were significantly decreased with the administration of 
ondansetron.  The study concluded that administration of ondansetron 4 mg five minutes 
prior to the spinal anesthetic reduces hypotension and vasopressor use in patients 
undergoing a cesarean section. 
Wang et al. (2014b) investigated the effects of administering ondansetron prior to 
spinal anesthesia by coloading crystalloid infusion after the administration with cesarean 
delivery.  The research extended previous studies that investigated the effect of 
preloading with crystalloid on hypotension.  Though there are benefits to this method, 
researchers concluded that delaying the spinal anesthesia for the nurse to deliver a fixed 
amount of crystalloid was not the best option. 
Wang et al. (2014b) continued their investigation by administering ondansetron 
prior to the cesarean sections, which would not require a delay in onset of anesthesia.  
These authors hypothesized that administering ondansetron prior to the spinal and 
crystalloid after the spinal would decrease the incidence of hypotension.  The study 
consisted of 62 women taking part in an elective cesarean section.  The women were 
placed into two randomly selected groups.  The group receiving ondansetron had a 
significantly lower incidence of hypotension and nausea than the placebo group (p=0.011 
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vs. 0.004).  The frequency of decreasing mean arterial pressure and systolic pressure were 
also lower in the group receiving ondansetron compared to the placebo group (p=0.008 
vs. 0.025).  This group also required less phenylephrine administration throughout the 
case.  The authors concluded the method used helped to significantly reduce maternal 
hypotension and nausea, and reduced the amount of vasoconstrictors used during the 
case. 
While studies have shown the benefits of using ondansetron on maternal 
hypotension when administering spinal anesthesia, one drawback has been that the 
different amounts of the drug were not fully investigated.  In Wang et al. (2014a) a dose-
dependent study was set up to determine the optimal dose for ondansetron.  One hundred 
and fifty women were divided up into five groups (n=150).  The groups consisted of a 
control placebo and administration groups receiving 2mg, 4mg, 6mg and 8 mg of 
ondansetron.  The group 4mg and 6mg showed a reduced incidence of maternal 
hypotension compared to other groups (p≤0.05).  Minimal changes from baseline in the 
mean arterial pressure, systolic blood pressure, and diastolic pressure appeared in these 
two groups.  The researchers concluded that while both doses provided the beneficial 
results, administration of 4mg ondansetron is the best option.  Administering 6mg or 
greater of ondansetron is related to lactate acidosis in the fetus.  The administration of 
less than 4mg ondansetron failed to show a reduced incidence of maternal hypotension.  
Four milligrams ondansetron was determined to be the optimal dose because of the dose 
ability to prevent maternal hypotension, decrease nausea and the reduced need for 
vasoconstrictors (Wang et al., 2014a).  
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The use of ondansetron for maternal hypotension is considered to be a newer 
intervention that is not entirely understood.  Ortiz-Gomez et al. (2014) performed a 
double-blind, randomized study to observe the effects of ondansetron and determine the 
optimal dose.  One hundred twenty-eight women undergoing elective cesarean sections 
receiving spinal anesthesia were involved in the study.  The women were randomly 
placed into four groups (n=32) and received either a placebo or 2 mg, 4 mg, 8 mg 
ondansetron dosages prior to spinal anesthesia.  The authors concluded there were no 
differences in the number of patients with hypotension: 14 patients (43.7%) in the 
placebo group, 17 (53.1%) in the 2 mg group, 18 (56.2%) in the 4 mg group, and 17 
(53.1%) in the group receiving 8 mg ondansetron (p=0.77).  There were also no 
differences found in the groups of patients requiring vasoconstrictors.  The study did not 
support administration of ondansetron prior to spinal anesthesia to reduce maternal 
hypotension.  The authors concluded that the findings showed there was little effect on 
the incidence of hypotension from administration of ondansetron in parturients 
undergoing spinal aesthesia. This effect might be due to differences in a particular 
population, sample size, study design, and anesthetic technique.  
Farmawy and Rashad (2013), performed a study to observe the effects of giving 
ondansetron or granisetron to patients undergoing spinal anesthesia for their cesarean 
section.  The authors investigated the effect of hypotension related to spinal anesthesia by 
observing the effects of the patient’s hemodynamics and sensory blockade.  Sixty women 
undergoing elective cesarean section were divided into three groups (n=20).  The first 
group, labeled O, had an injection of 4 mg of ondansetron mixed with 10 ml of normal 
saline.  The second group, labeled G, had an injection of 1 mg granisetron mixed with 10 
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ml of normal saline, and the third group, labeled S, had an injection of 10 ml of normal 
saline.  The results of the study concluded ondansetron was most effective in decreasing 
hypotension related to spinal anesthesia with lower vasopressor use (p< 0.05) and 
granisetron was more efficient in allowing the motor functions to come back sooner (p 
<0.05).  There was also a significant decrease in nausea in the groups administered 
ondansetron and granisetron (p = 0.008).  
The advancement of surgery and medicine has brought about new studies that will 
help in increasing positive outcomes of patients.  The articles in this literature review had 
varying results on the administration of ondansetron to help decrease the incidence of 
hypotension associated with spinal anesthesia.  Though the authors provided sufficient 
evidence to support the use of ondansetron, more studies and evidence need to be 
accumulated before making a final decision.  Safety and efficiency are the main 
objectives when caring for our patients.  Ondansetron has many beneficial uses in the 
clinical setting, to be able to use it to help prevent spinal anesthesia induced hypotension, 
as well as nausea and vomiting will be an added benefit.  A medication having multiple 
benefits and few disadvantages will ensure the patient receives the best care possible. 
Within this doctoral project’s clinical site, some providers administer ondansetron 
prior to spinal anesthesia and other providers do not.  The medical field is ever changing, 
and advances are being made on a daily basis.  Healthcare providers’ single goal is to 
provide the safest and most efficient care to patients.  In providing care to women 
receiving spinal anesthesia for a cesarean section, there are many potential problems that 
need to be addressed.  One of the main side effects of spinal anesthesia is hypotension 
(Farmawy & Rashad, 2013).  This side effect can cause many problems for the mother 
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and the neonate that has yet to be born.  The purposes of this doctoral project are to 
determine if ondansetron, a 5HT3 antagonist, helps reduce the hypotension associated 
with spinal anesthesia in women having a cesarean section, also if ondansetron use 
reduces the administration of vasopressors.  These clinical questions will be answered 
using a retrospective chart review.  In the sections that follow the method/data collection 
and analysis of the data will be discussed. 
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CHAPTER III  - METHODOLOGY 
The retrospective chart analysis took place at a hospital in the Southeastern 
United States.  The facility has 512-inpatient beds.  Patient information and record-
keeping is accomplished by using EPIC software.  Inclusion criteria consists of patients 
receiving spinal anesthesia for elective cesarean sections, ages 20-40 years, ondansetron 
only given prior to spinal anesthesia, ondansetron given in ten minutes or less before 
spinal anesthesia and met the American Society of Anesthesiologist’s (ASA) patient 
status classification I or II.  Exclusion criteria includes patients presenting for cesarean 
section with epidural due to failure to progress, ASA patient status classification III, IV 
or V, emergent cesarean sections, multiple parities (twins/triplets), > 1,000 ml blood loss, 
> 6 mg ondansetron administered, patients presenting with a cardiac history (coronary 
artery disease, myocardial infarction, congestive heart failure, murmur, mitral valve 
prolapse/regurgitation, dysrhythmias, aortic stenosis/regurgitation), patients taking blood 
pressure medication and patients presenting with preeclampsia.  After examining all data, 
a final inclusive data set was obtained.  A sample size calculator determined the sample 
size, and the confidence level and confidence interval needed to produce a significant 
result.  According to G power calculator with using a Chi square test the sample size will 
be 145, effect size 0.3 (medium), beta to alpha ratio .95,critical x2= 3.841458 and degrees 
of freedom 1.  A Chi-Square test can determine if there is a significant relationship 
between two variables, those variables being the use of ondansetron and the incidence of 
hypotension after spinal anesthesia in women undergoing elective cesarean sections and 
the use of ondansetron and the administration of vasopressors.  The independent variable 
consists of the usage of ondansetron and the non-usage of ondansetron. Dependent 
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variable are if hypotension does occur or does not occur, and if vasopressors are given or 
not. 
Procedures/Methods 
After IRB and hospital approval (See Appendix F), access to EPIC computer 
charting system was commenced.  Patients at this time were de-identified.  De-identifying 
the data was accomplished by deleting the patient identification number and substituting 
the number with a researcher generated unique identifier.  A data collection instrument 
(DCI) was used to record patient data. (See Appendix C).  The data collection instrument 
included subject number, age, ASA classification, diagnosis, previous cesarean sections, 
parity, hypotensive episodes, and administration of vasopressors.  The hypotensive 
occurrences were defined as having more than a 20% decrease in blood pressure from 
baseline blood pressure prior to spinal anesthesia. 
Analysis 
Retrospective results and a presentation were compiled using the information/data 
collection from the literature review and chart analyis.  This presentation was presented 
to the anesthesia providers at the facility where data were collected.  Data hygiene and 
unvariate analysis was used to look for outliers, miskeyed data and audits between data 
collection instrument (DCI) and every tenth subject ID.  A Chi square analysis was used 
to analyze data between the independent and dependent variables stated earlier in the 
methodology section.  All data collected were used to inform fellow anesthesia providers 
whether ondansetron reduced the incidence of low blood pressure in this hospital’s 
elective cesarean section patients, and also whether the use of ondansetron reduced the 
use of vasopressors. 
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CHAPTER IV – RESULTS 
This DNP project determined if administration of ondansetron prior to spinal 
anesthesia in elective cesarean section patients reduces hypotension and the use of 
vasopressors.  Variables examined were use of ondansetron, administration ten minutes 
or less prior to spinal anesthesia and usage of vasopressors up until the birth of the baby.  
A comprehensive literature review was conducted and results from the retrospective chart 
analysis were compiled within this doctoral project.   
This project utilized the Chi Square test to assess the relationships in receiving 
ondansetron prior to spinal anesthesia and not receiving ondansetron prior to spinal 
anesthesia and the effect this drug has on reducing hypotension and on the use of 
vasopressors.  The Chi Square test was executed by using SPSS (Statistical Package for 
the Social Sciences) by the researcher.  Results were considered significant if the p value 
was equal to or less than .05.   
Discussion of Results 
There were 812 patient charts reviewed.  Of the 812 charts, 57 met the inclusion 
criteria of receiving ondansetron ten minutes or less prior to spinal anesthesia, were 
between the ages of 20-40, and were an ASA class of I or II.  Out of the 812 charts, 57 
were also chosen that met all inclusion criteria except they did not receive ondansetron 
prior to spinal anesthesia, these charts were used to compare blood pressure values and 
vasopressor use to the prior 57 charts chosen. The 57 charts who did not receive 
ondansetron prior to spinal anesthesia were chosen on a first come, first serve basis.  The 
first 57 available charts that met the criteria were used.  Of the 114 charts used the 
minimum age was 20, maximum age of 39, with a mean age of 29.  The minimum parity 
 18 
was 0, the maximum parity was 10, with a mean parity of 1.  There were 7 patients who 
fell into the ASA I class, with 107 patients in ASA II class.   
A Chi Square test was conducted to examine hypotension in patients who did and 
did not receive ondansetron prior to spinal anesthesia in elective cesarean sections 
patients.  The test determined there was not a significant association between the 
hypotension group and whether or not they used ondansetron, N=114, df=1, x2 (1) = .035, 
p= .851 (Tables 1 & 2).  These results show there is no significant benefit of using 
ondansetron prior to spinal anesthesia to help reduce hypotension.  The second Chi 
Square test was done to investigate if less vasopressors were used up until the baby was 
born on those who received ondansetron.  There was a significant association between 
vasopressor use and whether or not they used ondansetron, N=114, df=1, x2(1) = 6.437, 
p= .011 (Tables 3 & 4). 
Table 1 Ondansetron and Hypotension Crosstabulation 
 Hypotension Total 
Hypotension 
No 
Hypotension 
Treatment Ondansetron 
Administered 
Count 
 
25 32 57 
Expected  
Count 
 
25.5 31.5 57.0 
No 
Ondansetron 
Administered 
Count 
 
26 31 57 
Expected 
Count 
25.5 31.5 57.0 
Total Count 
 
51 63 114 
Expected 
Count 
51.0 63.0 114.0 
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Table 2 Pearson Chi-Square Test Ondansetron and Hypotension 
 
Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 
 
.035 1 .851 
 
Table 3 Ondansetron and Vasopressor Crosstabulation 
 
 Vasopressor Total 
Some 
Vasopressor 
No 
Vasopressor 
Treatment 
Ondansetron 
Administered 
Count 
 
30 27 57 
Expected 
Count 
 
36.5 20.5 57.0 
No Ondansetron 
Administered 
Count 
 
43 14 57 
Expected 
Count 
 
36.5 20.5 57.0 
Total Count 
 
73 41 114 
Expected 
Count 
73.0 41.0 114.0 
 
Table 4 Pearson Chi-Square Test Ondansetron and Vasopressor 
 
Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 
 
6.437 1 .011 
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CHAPTER V – SUMMARY 
The main goals of this retrospective chart analysis were to show whether the 
administration of ondansetron prior to spinal anesthesia would help reduce hypotension, 
or the use of vasopressors  After performing Chi Square tests through SPSS, it was 
determined the use of ondansetron was not significant in reducing hypotension related to 
spinal anesthesia.  However, it was found that patients receiving ondansetron prior to 
spinal anesthesia were requiring less vasopressor use during their cesarean sections. 
Limitations 
There were limitations to this doctoral project.  If I had expanded inclusion 
criteria by increasing the amount of time prior to spinal anesthesia that ondansetron was 
given it may have increased the numbers of patients available for the study, thus 
providing more charts to review and increasing the study’s power.  Increasing the sample 
size could have been what the study needed to meet the power analysis and show a 
significance between ondansetron usage and reduction in hypotension.  Increasing the 
amount of time prior to the spinal anesthetic could have also been beneficial in that it 
would allow the medication longer to take effect and could have possibly made more of a 
change in hypotension.  Use of a randomized sample could have been used to reduce bias 
when performing a retrospective chart review.  Another possible limitation to this project 
is the fact that the medication could have been given outside the measurement period, 
which in turn would skew the study’s results. 
Barriers 
One of the main barriers to this project are the multiple definitions in hypotension.  The 
literature states “hypotension being defined as a blood pressure of less than 20% of the 
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baseline or preoperative blood pressure” (Nagelhout & Plaus, 2014, p. 1229).  Literature 
also states that the practitioner should look at clinical signs, such as, nausea and loss of 
consciousness, and not just look at numeric signs of hypotension (Nagelhout & Plaus, 
2014).  Clinically most practitioners will treat a systolic blood pressure less than 100 
regardless if it is 20% of baseline or not.  This causes a barrier to the study, because some 
practitioners may be treating the blood pressure with vasopressors before a 20% drop is 
ever detected, they may just be treating based off of clinical signs. 
Future Directions 
This doctoral project can definitely be expanded in the future.  Taking into 
consideration the limitations and possible changes that can be made to the project there is 
room to show more possible benefits of using this medication prior to spinal anesthesia.  
A closer examination of the decreased usage of vasopressors could be a major benefit in 
the use of ondansetron and bring about a possible practice change.   
Conclusion 
Spinal anesthesia is the most common anesthetic used when performing elective 
cesarean sections.  Hypotension is one of the most common side effects experienced after 
performing spinal anesthesia.  This side effect can be harmful to mother and the unborn 
child if gone untreated.  This doctoral project was performed to look at administering 
ondansetron prior to spinal anesthesia in elective cesarean section patients in helping to 
reduce hypotension.  In trying to determine if ondansetron will help in reducing the 
incidence of hypotension with spinal anesthesia associated with cesarean sections, 
scholarly databases and peer-reviewed articles were used to obtain the evidence.  A 
spread matrix was constructed to bring together all information discussed in the literature.  
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The project results showed that there was no significant association between ondansetron 
and hypotension, but did show a significant association between ondansetron and 
decreased vasopressor use in this clinical setting.  Decreasing the use of vasopressors 
helps in reducing the chance of causing issues to the unborn child and decreases the 
amount of medications being given to mother and baby before birth.  Ondansetron is a 
medication that is typically given at some point during the cesarean section to help with 
nausea.  This project has shown that giving it prior to spinal anesthesia can help decrease 
medication usage and can in turn still help with the unwanted nausea during the case.  
Information from this study was compiled and presented to anesthesia providers at a local 
hospital.  There was a definite interest in the findings and a possible practice change 
indicated verbally among some of the providers.  As with any new finding and 
educational material, there are still some who are hesitant to change, especially when 
dealing with an unborn child.  Hopefully the disseminated information will be passed on 
so providers will see the benefits of using ondansetron in their practice. 
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APPENDIX A – Literature Matrix 
 Author        Year     Design     Framework       Sample             Findings        Notes 
 
 
 
Rashad and Farmawy 2013 Quantitative None
60 pregnant woman (20 per 
group), ASA I-II, aged 20-40, 
scheduled for elective 
cesarean
1. 4mg ondansetron 
significantly decreased 
hypotension and vasopressor 
use; IV granisetron induced 
faster sensory recovery
2. MAP were significantly 
lower in group O (n=20, 
P <.05)than groups G (n=20, 
P <.05) and S (n=20, P <.05) 
with lower vasopressor use
3. Faster sensory recovery in 
group G (n=20, P <.05) than 
groups O (n=20, P <.05) and S 
(n=20, P <.05)
4. Significant decrease in 
nausea in groups O (n=20, 
P =0.008) and G (n=20, 
P =0.008) than S (n=20, 
P =.008)
Wang, M. et al. 2014
Dose-dependent 
study None
150 pregnant women (30 per 
group), ASA I-II, aged 18-35, 
37-42 weeks of gestation
1. Compared to group 
S(placebo), the incidence of 
maternal hypotension was 
sigificantly lower in groups 
O4 (n=30, P <0.05) and O6 
(n=30, P <0.05).
2.The umbilical venous pH 
was significantly higher in O4 
(n=30, P <0.05, O6 (n=30, 
P <0.05), and O8 (n=30, 
P <0.05); and the bicarbonate 
and base excess in 
extracellular fluid were 
significantly lower in groups 
O6 (n=30, P <0.05) and O8 
(n=30, P <0.05).
3. Minimal changes of 
systolic blood pressure, 
diastolic blood pressure, and 
mean arterial blood pressure 
were observed in group O4 
(n=30, P <0.05)
Owczuk et al. 2008
Double-blind, 
placebo controlled 
study None
71 individuals, 2 groups (36 
in ondansetron group, 35 in 
placebo group), ASA I-II, 
age 20-70
1. Decreases in mean, 
systolic, and diastolic arterial 
pressure as well as in heart 
rate, compared with baseline 
valuesvalues were observed 
in both groups.
2. Minimal systolic and mean 
blood pressure values 
obtained over a 20-minute 
observation period were 
significantly higher in the 
ondansetron group.
3. There were no significant 
differences in diastolic blood 
pressure and heart rate values 
between the groups.
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Sahoo et al. 2011
Double-blind, 
randomized, placebo-
controlled study None
52 pregnant women having a 
cesarean section(Group 
O=26, Group S=26), ASA I, 
age 20-40
1. Decreases in mean arterial 
pressure were significantly 
lower in Group O than Group 
S.
2. Patients in Group O (n=26) 
required significantly less 
vasopressor (P =0.009) and 
had significantly lower 
inceidences of nausea and 
vomiting (P=0.049).
Ortiz-Gomez et al. 2014
Double-blind, 
randomized, placebo-
controlled trial None
128 healthy pregnant women 
having a cesarean section, 4 
groups ( n=32 per group), 
ASA I, age 20-45
1. There were no differences 
in the number of patients with 
hypotension in the placebo 
(43.8%, n=32, P =0.77) and 
ondansetron 2mg (53.1%, 
n=32, P =0.77), 4 mg (56.3%, 
n=32, P =0.77), and 8 mg 
(53.1%, n=32, P =0.77).
Wang, Q. et al. 2014 Quantitative None
66 women having a cesarean 
section, 2 groups (n=33 per 
group),ASA I-II, age 18-35, 
37 to 42 weeks gestation
1.Maternal hypotension and 
nausea were significantly 
lower in ondansetron treated 
patients (n=33, P =0.011) 
versus placebo (n=33, 
P =0.004).
2. Decreases in maternal 
sustolic and mean arterial 
pressures were significantly 
lower in ondansetron treated 
patients (n=33, P =0.008) 
versus placebo (n=33, 
P =0.025), with less requirment 
of pehnyephrine 
administration compared with 
controls (P =0.029).
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APPENDIX B – Doctor of Nursing Essentials 
 
DNP ESSENTIALS CLINICAL IMPLICATIONS 
Essentials I- Scientific underpinnings for 
practice 
Using the most up to date and safest evidence 
to prevent injury to the patient while using 
spinal anesthesia 
Essentials II- Organizational and systems 
leadership for quality improvement and 
systems thinking 
The administration of ondansetron may reduce 
hypotension related to spinal anesthesia, 
without the negative effects of other 
medications. This in turn will bring about 
implementation of policies to improve patient 
outcomes 
Essentials III- Clinical scholarship and 
analytical methods for evidence based practice 
Using a Chi square test to analyze data 
between two groups, involving independent 
and dependent variables 
Essentials IV- Information systems or 
technology and patient care technology for the 
improvement and transformation of healthcare 
Performing a retrospective chart review patient 
data will be removed from their electronic 
medical record and protected avoid ethic/legal 
issues. Electrical databases will be used for 
review of literature and to obtain information 
regarding ondansetron and spina anesthesia on 
cesarean section patients 
Essentials V- Healthcare policy for advocacy 
in healthcare 
If information from this doctoral project 
indicates ondansetron does help in the 
reduction of hypotension related to spinal 
anesthesia in cesarean section patients, then a 
practice change can be implemented to provide 
better patient safety and increase overall 
patient satisfaction 
Essentials VI- Interprofessional collaboration 
for improving patient and population health 
outcomes 
Collaboration between anesthesia providers is 
pivotal to bringing about a practice change. 
Each provider has vital information and 
suggestions that can help bring about a change 
and help in providing the safest care to the 
patient population. Collaboration between the 
EPIC staff and the researcher in being able to 
gather information needed for this study. 
Essentials VII- Clinical prevention and 
population health for improving the nation’s 
health 
The use of such medications as ephedrine 
though effective, can cause decreased 
uteroplacental perfusion.  This project will 
evaluate using ondansetron in helping reduce 
the incidence of hypotension to help in either 
decreasing or alleviating the use of pressors 
such as ephedrine all together in the pregnant 
patient population, which in turn would 
improve patient outcomes 
Essentials VIII- Advanced nursing practice Applying evidence based practice and 
advanced clinical knowledge to maintain and 
provide the safest care to patients receiving 
anesthesia 
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APPENDIX C –Data Collection Table 
 
 
 
 
Age ASA Diagnosis Elective 
C-section 
Parity Hypotension Vasopressor 
Use 
Ondansetron 
Use Prior to 
Spinal 
Ondansetron 
Given 10 
min or Less 
Before 
Spinal 
Subject1          
Subject2          
Subject3          
Subject4          
Subject5          
  
2
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APPENDIX D  - Logic Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assumptions
•Reducing the 
incidence of 
hypotension related 
to spinal anesthesia 
is important  to 
healthcare 
personnel
•Preventing 
unwanted side 
effects and issues 
with hypotension 
related to spinal 
anesthesia is 
important to 
healthacre workers 
and patients
Resources
•Research Articles
•Time needed to 
review articles and 
literarure reviews
•Time needed to 
comb through 
patient information 
to include in data 
collection
Activities
•Use of literature 
reviews involving 
evidence based 
practices
•Selecting articles 
best suited for the 
project based on 
evidence based 
practice and 
incidence of 
hypotension in 
cesarean section 
patients receiving 
spinal anesthesia
•Reviewing and 
assessing records
Outputs
•Educational material
•White paper 
proposal
•Literature review
Outcomes
•Initial
•Decrease incidence of 
hypotension
•Provide knowledge to 
staff about the use of 
ondansetron
•Intermediate
•Shorter recovery 
time/hospital stay
•Decreased incidence of 
syncope, 
nausea/vomitting, and 
heart related issues
•Long-Term
•Decreased incidence of 
ischemia
•Decreased costs for 
long term care
•Changing of hospital 
policy regarding 
medition used for 
spinal anesthesia
  
2
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APPENDIX E - SWOT 
 
 
 
 
 
 
 
 
 
 
 
Strengths Weaknesses 
 No additional costs or extra work for the clinical site 
 Retrospective chart review 
 Inadequate documentation by the provider 
 
 Variables cannot be controlled in a retrospective 
chart analysis 
Opportunities Threats 
 Change in practice for the facility 
 Increases patient satisfaction scores and overall 
experience 
 Ondansetron having no effect on decreasing 
hypotension in patient population 
 
 Anesthesia providers unwillingness for practice 
change 
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APPENDIX F – IRB Letters of Approval 
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